|
Dr. Liu is the founder and CEO of Eureka Therapeutics, Inc. Prior to founding Eureka, Dr. Liu served as a principal scientist in Antibody Drug Discovery at Chiron (now part of Novartis). Dr. Liu has 20 years of experience in biology research and drug discovery with extensive experience and knowledge in cancer therapeutic antibody discovery and development, including target identification, validation, assay development, and screening for drug candidates. He is the inventor of 14 patents filed in the US and Europe. He also served as president of SAPA-West from 2004-2005 and on its Executive committee and Adversory committee from 1998-2007. Dr. Liu received his B.S. in Genetics from Beijing University, M.S. in Molecular Biology from Beijing University, and a Ph.D. in Molecular Cell Biology from the University of California, Berkeley. | 